Table 2.
Trial | Coded variables |
Actinomycin D (mgL−1) | |||||
---|---|---|---|---|---|---|---|
x1 | x2 | x3 | x4 | x5 | x6 | ||
1 | - | + | - | - | - | + | 191.59 ± 1.41 |
2 | - | + | + | + | - | + | 278.85 ± 14.14 |
3 | - | - | - | + | + | + | 290.26 ± 5.64 |
4 | + | + | + | - | + | + | 153.28 ± 9.89 |
5 | - | + | + | - | + | - | 206.87 ± 9.88 |
6 | + | - | + | - | - | - | 180.31 ± 11.31 |
7 | + | - | - | - | + | + | 163.68 ± 8.48 |
8 | - | - | + | + | + | - | 168.88 ± 7.07 |
9 | + | - | + | + | - | + | 122.92 ± 2.82 |
10 | - | - | - | - | - | - | 479.74 ± 9.89 |
11 | + | + | - | + | - | - | 154.82 ± 4.24 |
12 | + | + | - | + | + | - | 103.17 ± 8.48 |